Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
2023 · The Lancet · 220 citations
https://doi.org/10.1016/s0140-6736(23)00222-2
R
Rana Fayyad
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
4.8K
Citations
34
h-index
58
i10-index
Rana Fayyad is an academic researcher from Siemens Healthcare (United States). The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Treatment of Major Depression & Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes. The author has an h-index of 34, co-authored 97 publications.
Papers by this author
worksA Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites
2012 · Neuropsychopharmacology · 71 citations
https://doi.org/10.1038/npp.2012.153
Assessing the relationship between functional impairment/recovery and depression severity
2011 · International Clinical Psychopharmacology · 47 citations
https://doi.org/10.1097/yic.0b013e32834c2488
An Evaluation of Sexual Functioning in Employed Outpatients with Major Depressive Disorder Treated with Desvenlafaxine 50mg or Placebo
2012 · The Journal of Sexual Medicine · 29 citations
https://doi.org/10.1111/j.1743-6109.2012.02899.x
Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine
2014 · International Clinical Psychopharmacology · 27 citations
https://doi.org/10.1097/yic.0000000000000031
Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder
2014 · CNS Spectrums · 22 citations
https://doi.org/10.1017/s1092852914000066
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat